SUMMARY
INTRODUCTION
Fumarate reductases (FRDs) catalyse the reduction of fumarate to succinate and can be divided into two classes of enzymes: those belonging to a multimeric complex associated with the respiratory chain and transferring electrons from a quinol to fumarate, and the soluble enzymes, which transfer electrons from a non-covalently bound cofactor (NADH or FADH 2 /FMNH 2 ) to fumarate. Most of the FRDs characterized so far belong to the first class (1) . These FRDs are structurally similar to succinate dehydrogenases (SDH), complex II of the respiratory chain. The Shewanella putrefaciens FRD is functionally equivalent to the membrane bound enzymes by accepting/transferring electrons from/to the respiratory chain, but is a soluble enzyme lacking a membrane anchor (2) . To date, only two examples of soluble FRDs not linked to the respiratory chain (second class) have been described. The yeast Saccharomyces cerevisiae expresses two soluble FRDs (cytosolic and promitochondrial) that use FADH 2 /FMNH 2 as electron donor (3, 4) , and the African trypanosome Trypanosoma brucei expresses a soluble NADH-dependent FRD located in the peroxisome-like organelle, called glycosome (5, 6) . A phylogenetic analysis of FRDs and SDHs showed that the membrane bound enzymes form a monophyletic group distantly related to the soluble enzymes, including the Shewanella putrefaciens FRD (5). In 1980, H.
Gest proposed that the membrane bound FRDs evolved from an ancestral soluble enzyme and that the new features contributed to improvement of the energy-transducing system (7) . In this model, the primitive organisms used anaerobic lactic fermentation of hexoses to generate energy. The metabolism subsequently evolved to "succinic fermentation" by introducing a couple of new enzymes, including a soluble FRD that was possibly NADH-dependent (7, 8) .
Then, association of FRD with the electron transfer chain in the membrane of the mitochondrion (first class of FRD) evolved to increase the rate of ATP production. The soluble FRDs of yeast and trypanosomes might therefore be the closest relatives of the ancestral FRD characterized so far.
Trypanosomatids are protozoan parasites of major medical and veterinary significance. They cause serious diseases in humans such as sleeping sickness (T. brucei), - 
-
The energy metabolism of the T. brucei bloodstream form is unique among trypanosomatids. This form relies entirely on glycolysis (which takes place in the glycosome) with pyruvate as the main excreted end product, while the mitochondrion plays a minor role (13) . In contrast, the T. brucei procyclic form and the other adaptative forms of trypanosomatids have a more elaborate energy metabolism that is characterized by aerobic fermentation of glucose, with excretion of partially oxidized end products, such like succinate, acetate and lactate (13) (14) (15) (16) . The original model of the glucose metabolism in the procyclic trypanosomes, established 20 years ago (13) , has recently been revised (17) . In the updated model (Fig. 1, grey arrows) , part of the phosphoenolpyruvate (PEP) produced in the cytosol enters the glycosome to produce succinate, which is excreted (steps 13, 15-17) (5).
The other part of PEP is used to produce pyruvate through pyruvate kinase in the cytosol (step 12) (5,18). Then, pyruvate enters the mitochondrion to produce acetyl-CoA and then acetate (steps 21-24) (19, 20) . Moreover, it was shown that acetyl-CoA is not metabolized in the tricarboxylic acid cycle (21) and that substrate level phosphorylation is essential for ATP production when glucose is the major carbon source (18, 22) .
Succinate is the main end product excreted by procyclic trypanosomes grown in SDM79 medium, which contains both glucose and proline. Proline is stoichiometrically converted to succinate and carbon dioxide in the mitochondrion (21) . Approximately 70% of the excreted end products derived from glucose metabolism is also succinate, most of it being produced by the glycosomal NADH-dependent FRD (FRDg) (5) . However, the origin of the remaining glucose-derived succinate is unknown and we proposed that another NADH-FRD may be involved (5) . In the 90's the existence of fumarate reductase in trypanosomatids was highly controversial (23) (24) (25) . Turrens and co-workers identified a soluble NADH-FRD activity in fractions enriched for mitochondrial markers in T. brucei and T. cruzi (6, 26, 27 ).
However, it was suggested that this activity might correspond to a reversal of the reaction catalyzed by the mitochondrial SDH (23) . The involvement of a putative mitochondrial NADH-FRD in the production of succinate is still debated. Here, we describe two new FRD genes (FRDm1 and FRDm2) present in the genome of T. brucei, which are similar to the glycosomal FRDg gene. FRDm1 is expressed in the mitochondrion of procyclic trypanosomes, whereas the FRDm2 gene product is not detectable. By using a combination of RNAi and NMR analysis of D-[1-
13 C]-glucose metabolism, we showed that FRDm1 is responsible for ~30% of the total cellular NADH-FRD activity and for the production of approximately ~25% (between 14% and 44%) of the excreted succinate from glucose metabolism. The role of FRDm1 in the energy metabolism of the procyclic trypanosomes and the regulation of glucose metabolism will be discussed.
EXPERIMENTAL PROCEDURES
Cell cultures -The procyclic form of T. brucei EATRO1125 was cultured at 27°C in SDM79 medium containing 10% (v/v) heat-inactivated fetal calf serum and 3.5 mg.ml -1 hemin (SDM79/FCS) (28) . The bloodstream form of T. brucei AnTat1 was grown in rats and isolated by DEAE ion exchange chromatography, as previously described (29) . using specific oligonucleotides as primers, as described by the manufacturer. DNA and amino acid sequences were analyzed using the DNA STRIDER program and database searches were done with BLAST. Multiple alignments of amino acid sequences were obtained using MacVector 6.0.1 and the MITOPROT program (http://mips.gsf.de/cgibin/proj/medgen/mitofilter) was used to determine the putative mitochondrial targeting signal.
Cloning and sequencing of the FRD genes -

Inhibition of FRDg and/or FRDm1 genes expression by RNA interference (RNAi) -
The inhibition by RNAi of FRDm1 and/or FRDg expression in the procyclic forms (9) was performed by expression of stem-loop "sense/anti-sense" molecules of the targeted sequences produced by overlapping PCR chimerical sense and anti-sense molecules composed of the DNA fragments used to target FRDg and FRDm1. For the chimeric sense molecule, we generated by PCR an FRDg-S fragment flanked by HindIII (5'-extremity) and the first 20 bp of the FRDm1-S fragment (3'-extremity), and an FRDm1-S fragment flanked by the first 20 bp of the FRDg-S fragment (5'-extremity) and XhoI (3'-extremity). Then, the sense chimeric fragment was produced by overlapping PCR, using as primers the 5' and 3' primers used to PCR-amplify the FRDg-S and FRDm1-S fragments, respectively, and as matrix the gelpurified FRDg-S and FRDm1-S fragments. The resulting 926 bp PCR fragment is composed of the FRDg gene/3'-UTR fragment (453 bp) followed by the FRDm1 gene/5'-UTR fragment (449 bp) and flanked by the HindIII (5'-extremity) and XhoI (3'-extremity) restriction sites.
We used the same approach to generate the chimeric anti-sense molecule, which is composed of the FRDm1-AS fragment containing a 50 bp extension as compared to the FRDm1-S fragment (spacer between the sense and anti-sense chimeric sequences) followed by the (33) . Immunodetection was performed as described (33, 34) using as primary antibodies, the monoclonal mouse anti-PPDK (H112) undiluted (32), the monoclonal anti-tubulin (diluted 1:100) (Sigma), the rabbit anti-FRDg (diluted 1:100) (5), the rabbit immunoadsorbed anti-FRDm1 (diluted 1:50) or the rabbit anti-FRD (diluted 1:100), and as secondary antibodies, anti-mouse or anti-rabbit IgG conjugated to horseradish peroxidase (BioRad), respectively.
Expression of EGFP-tagged FRDm1 in trypanosomes -
Immunofluorescence analyses -log phase cells were fixed with formaldehyde as described before (32 Mannheim, Germany). Cell aliquots (300 ml) were incubated 4 min at 25°C with increasing concentrations of digitonin, before being centrifuged at 14,000 g for 2 min, as described before (37) .
Enzymatic assays -Sonicated (5 sec at 4°C) crude extracts of trypanosomes resuspended in cold hypotonic buffer (10 mM potassium phosphate, pH 7.8) were tested for enzymatic activities. NADH-dependent FRD and glycerol-3-phosphate dehydrogenase activities were measured at 340 nm via oxidation of NADH, according to published procedures (5).
D-glucose measurements in growth medium -
To determine the rate of D-glucose consumption, 10 9 procyclic cells (exponential phase) were collected by centrifugation, washed in PBS buffer and resuspended in 10 ml of fresh SDM79 medium containing 10% calf serum. The cells were incubated for 8 h and samples (50 ml) were collected at 30 min intervals. Each sample was centrifuged at 14,000 g for 30 sec and the quantity of D-glucose remaining in the supernatant was determined using the "Glucose Trinder" (Sigma) or "Glucose GOD-PAP" (Biolabo SA) kits. (39), wherein the detection of protons bound to 13 C is based on the spin-spin coupling between directly bound 1 H and 13 C nuclei (J CH = 127 Hz). Two spectra were recorded from each sample, the first corresponded to protons bound to 12 C and 13 C carbons (spin echo spectrum), and the second to protons bound to 13 C carbons ( 13 C-edited NMR spectrum). Flip angles for rectangular pulses were carefully calibrated on both radiofrequency channels before each experiment. The relaxation delay was 8 sec for a nearly complete longitudinal relaxation. The fractional 13 C-enrichment at selected metabolite carbon positions was calculated as the ratio of the area of a given resonance in the 13 C-edited NMR spectrum to its area in the standard spin-echo spectrum. The reproducibility and accuracy of the method were assessed using several mixtures of 13 C-labeled amino acids and lactate with known fractional enrichments; the relative errors in the 13 C-enrichment determinations were <5% (M. Biran et al., unpublished data). (Fig. 3) . As previously reported, the 120 kDa protein is also recognized by the specific anti-FRDg antibodies (Ref. (5) and Fig. 3 ), whereas the 130 kDa protein is specifically recognized by the anti-FRDm1 antibodies (Fig. 3) . Thus, the 120 and 130 kDa proteins correspond to FRDg and FRDm1, respectively, and FRDg seems to be more abundant than FRDm1 in procyclic cells. We also noticed a very weak signal with the anti-FRD serum in the range of 90 kDa, which might correspond to the FRDm2 isoform (Fig. 3) .
Nuclear magnetic resonance (NMR) experiments -
RESULTS
Three fumarate reductase (FRD) genes in T. brucei -
Expression of FRD isoforms -
However, several lines of evidences (see Discussion) indicate that FRDm2 is not expressed and that this weak and poorly reproducible signal is not related to FRDm2 and more likely corresponds to a degradation product of either FRDg or FRDm1. In the bloodstream form sample, very low intensity bands comigrating with the FRDg (120 kDa) and FRDm1 (130 kDa) bands in the procyclic sample suggest weak expression. However, the nature of the doublet comigrating with FRDg in the bloodstream form sample, is still unclear and is under investigation.
FRDm1 is a mitochondrial protein -The subcellular localization of FRDm1 was studied by immunofluorescence with the specific anti-FRDm1 immune serum (Fig. 4) . To further confirm the mitochondrial localization of FRDm1, we expressed a fusion protein composed of the first 800 amino acids of FRDm1 followed by the Enhanced Green Fluorescent Protein (EGFP) in procyclic trypanosomes. This EGFP-tagged FRDm1, detected
by direct fluorescence analysis, shows a "mitochondrial-like" pattern that colocalizes with the mitochondrial hps60 marker (Fig. 4C) . Moreover, a truncated form of the EGFP-tagged FRDm1 recombinant protein that lacks the 68 N-terminal residues relocalized to the cytosol of the procyclic trypanosomes (Fig. 4D) . These results indicate that the predicted N-terminal signal motif of FRDm1 is required for targeting to the mitochondrion.
FRDm1 encodes a NADH-dependent fumarate reductase -
We have previously reported that inactivation of FRDg expression by RNA interference (RNAi) caused a ~70% reduction of the NADH-dependent fumarate reductase activity in the mutant cell lines as compared to the wild type cell line. Moreover, this activity was not detectable in glycosomes purified from the mutant (5). We proposed that FRD encoded by (an) additional gene(s) might account for the remaining 30% NADH-dependent fumarate reductase activity. Therefore, we generated mutant procyclic cell lines for RNAi-mediated repression of FRDm1 alone or of both FRDm1
and FRDg (9) . The pLew79 vector (31) was used to produce the hairpin double stranded RNA (dsRNA) molecules, as described before (5, 10, 18, 20) . The recombinant pLew79-derived plasmids were introduced into the EATRO1125.T7T cell line expressing the tetracycline repressor (10, 31) . We have selected five clonal cell lines, designated DFRDm1-B4, DFRDm1-G7, DFRDg/m1-B5, DFRDg/m1-C6 and DFRDg-C2, the latter one being a DFRDg clone different from the one previously analyzed (5). In the absence of tetracycline, the expression of the hairpin dsRNA is inhibited by the tetracycline repressor, which binds to the tetracyclin operator located between the transcription promoter and RNAi cassette. Nevertheless, all five uninduced cell lines analyzed show 9 to 40% reduction of the NADH-FRD activity (see Fig. 6 and Table I) , probably due to a leakage of the inducible expression system, as previously observed (5, 10, 18, 20, 31) . After 7 days of tetracycline induction, the proteins encoded by the RNAi-repressed gene(s) were not detectable anymore by Western blot analysis, for all five cell lines analyzed (Fig. 6 ). Pyruvate phosphate dikinase (PPDK) expression, serving as specificity control, was not affected. After seven days of induction, the DFRDg cell line (DFRDg-C2.i) showed a 69% reduction of the NADH-FRD activity compared to the untransfected EATR01125.T7T cell line (22 ± 3 versus 70 ± 4.9 mU.mg -1 of protein) ( Table I , mutant cell lines show a reduced rate of glucose consumption, as compared to the wild type cells (Fig. 7) Fig. 8 ). For both DFRDg/m1 clones (B5 and C6 in Table I ) NMR analyses were performed at different time points after induction to compare different levels of repression. These analyses led to six main observations. First, the rate of excretion of 13 Cenriched molecules is 1.4-to 1.7-times reduced in induced mutant cell lines, as compared to the wild type or non induced cell lines (Table I) , which is in agreement with the observed reduction of the D-glucose consumption rate (Fig. 7) . Second, significant correlations were seen between the level of NADH-FRD activity and the relative amounts of excreted succinate, malate and fumarate (Fig. 9) . The quantitative correlation between the NADH-FRD activity and the amount of excreted succinate, the product of FRD, confirmed that FRDm1 and FRDg confer NADH-FRD activity in vivo. This is also supported by the inverse correlation between NADH-FRD activity and fumarate (substrate of FRD) and malate excretion. The accumulation of malate is probably due to fumarase activity, which reversibly converts the accumulated fumarate into malate (steps 16, 31 in Fig. 1 ). Third, inhibition of FRDm1 expression induces a 7% (induced DFRDm1-B4 clone) and 14% (induced DFRDm1-G7 Fig. 9 ). Acetate is produced from acetyl-CoA by ASCT, which transfers the CoA to succinate, to produce succinyl-CoA and by at least one additional uncharacterized reaction (19, 20) (steps 22, 23 in Fig. 1 ). Interestingly, there is a direct correlation between reduction of acetate and succinate excretions (Fig. 9 ), suggesting that a high intramitochondrial succinate concentration is required to support acetate production by the ASCT, as previously proposed (19) . Sixth, all the mutant cell lines show a significant production of 13 C-enriched glycerol, while this end product is not detected in the EATRO1125.T7T supernatant. Glycerol is produced in the glycosome from DHAP through the formation of glycerol-3-phosphate followed by a reversal of the glycerol kinase reaction (step 7 in Fig. 1 (17): part of the malate produced inside the glycosome should be transferred to the mitochondrion to be converted by fumarase and FRDm1 to succinate (black arrows in Fig. 1 ).
Thus, succinate excretion results from a flux through part of the TCA cycle in the reverse sense.
Turrens and colleagues described a NADH-FRD activity in procyclic trypanosomes, which cofractionated with other mitochondrial enzyme activities (27) , however, direct evidence for the subcellular localization was missing. The identification of FRDm1 as the mitochondrial NADH-FRD seems to bring the long-standing debate regarding the existence and the subcellular localization of FRD enzymes in trypanosomatids (23) (24) (25) to an end. NADH-FRD activity was also detected in mitochondrial extracts of T. cruzi (26, 44) and Leishmania donovani (45) . In agreement with these biochemical data, the recently sequenced L. major and T. cruzi genomes contain one and two FRD genes with putative mitochondrial targeting motifs, respectively, in addition to a glycosomal FRD gene (data not shown). In the T. congolense procyclic form (46) and Phytomonas sp. (47) also a NADH-FRD activity was found, although its subcellular localization is unknown. Since all trypanosomatids analyzed to date, with the exception of the bloodstream form of T. brucei, excrete succinate under aerobic conditions (14) and express NADH-FRD activity, the proposed model of glucose catabolism might be extended from T. brucei to the other trypanosomatids.
Membrane bound succinate dehydrogenase (SDH) activity (complex II of the respiratory chain, step 29 in Fig. 1 ), which produces fumarate from succinate (the reverse of the NADH-FRD reaction, but with ubiquinone as the electron acceptor instead of NAD + ), has been detected in several trypanosomatids, including T. brucei (44, 48, 49) . The presence of both SDH and NADH-FRD activities in the same subcellular compartment may generate a futile cycle and be detrimental for the cells. Turrens and colleagues showed that, in isolated mitochondrial fractions, succinate is the main electron donor to the respiratory chain and proposed a model involving both FRD and SDH, the latter having a central role (50) .
However, the analysis of SDH-depleted procyclic trypanosomes does not support this hypothesis, since the ATP production and cell growth are not affected in the mutant cell line (22) . Actually, one may consider that detectable SDH activity in an in vitro assay does not necessarily imply that it functions in vivo, under the conditions studied, as clearly illustrated by the apparent absence of a carbon flux through the complete TCA cycle in procyclic trypanosomes (21) . Also, proline is converted quantitatively to succinate and carbon dioxide as final excreted/released end products (21) . The absence of net production of fumarate or malate from proline, sustains the view that SDH is not important in procyclic trypanosomes under standard growth conditions (see Fig. 1 ).
The presence in the mitochondrion of an aerobic organism of SDH, which is a hallmark of aerobic eukaryotes, and FRD only found in anaerobic organisms is rather unique and seems a like contradiction. The procyclic trypanosomes need oxygen, which is the only terminal electron acceptor used to maintain the respiratory chain activity. However, in the presence of glucose, these parasites behave like anaerobic organisms. Indeed, the consumed carbon sources (mainly glucose, proline and threonine) are converted into partially oxidized end products (succinate, acetate, lactate and glycine) by the so called aerobic fermentation (13) (14) (15) (16) 51) and ATP is primarily produced by substrate-level phosphorylation (22, 52) .
Consequently, the presence of a FRD in the mitochondrion of these parasites is not surprizing.
However, the data do not support a role for the mitochondrial SDH under the conditions analyzed (glucose-rich medium) and therefore the role of this enzyme, typical of aerobic metabolism, in procyclic trypanosomes remains unclear.
In the absence of detectable NADH-FRD activity and detectable FRD proteins (DFRDg/m1 cell lines), the production of succinate is reduced by 92% as compared to the wild type cells. The limitations of our assays leave it open whether additional activity due to the presence of a different fumarate reductase, or residual activity as a result of incomplete RNAi-mediated repression may account for the remaining 8% of excreted succinate. The We previously proposed that FRDg, which catalyses the last step of the glycosomal succinate producing pathway, is involved in the maintenance of the glycosomal redox balance by oxidizing NADH into NAD + (5). Indeed, since PYK consumes part of the PEP produced in the cytosol (step 12 in Fig. 1) (5,18) , both the glycosomal malate dehydrogenase and FRDg activities (steps 15, 17 in Fig. 1 ) may be required to reoxidize all the NADH produced by the glycosomal glyceraldehyde-3-phosphate dehydrogenase (step 8 in Fig. 1 ). In yeast, this function of maintaining the redox balance is, at growth under anaerobiosis, exerted by the cytosolic FRDS and mitochondrial OSM1, the other known soluble FRDs (FADH 2 /FMNH 2 -dependent enzyme) (3, 4) . Interestingly, the succinate production pathways in trypanosomatids (and in anaerobically grown yeast) resembles the "succinic fermentation" supposed to be developed from the lactic fermentation by primitive anaerobic organisms, to increase their capacity of oxidizing the NADH resulting from sugar fermentation in conjunction with a development towards more metabolic complexity (e.g. availability of metabolites and free energy retrieval from the substrate by subsequent coupling of FRD to respiratory chain) (7).
We propose that in trypanosomatids a branched version of the primitive "succinic fermentation" evolved to provide more flexibility to the capacity of controlling the redox balance in both the glycosomal and mitochondrial compartments. This view suggests that
FRDm1 plays a role in reoxidation of the NADH produced in the mitochondrion by the glucose and proline metabolism (steps 21, 28, 34, 36 in Fig. 1 ).
The mitochondrion of procyclic trypanosomes contains at least two other NADH dehydrogenases, which transfer electrons from NADH to the respiratory chain, one is rotenone-sensitive (complex I of the respiratory chain) and the other rotenone-insensitive (54, 55) . However, the relative contribution of these different NADH consuming enzymes in the maintenance of the mitochondrial redox balance, is unknown. In this context it is interesting to note that the amount of glucose-derived succinate produced in the mitochondrion (between 14% and 44% of total end product) is in the same range as the amount of glucose-derived acetate produced in the mitochondrion (~20% of total excreted end products). The mitochondrion produces one NADH per acetate (pyruvate dehydrogenase complex, step 21 in Fig. 1 ), while one molecule of NADH is consumed by FRDm1 per molecule of succinate produced. Although this observation may be incidental, the redox balance in the mitochondrion might be maintained by an equimolar production of succinate and acetate. There is other evidence that the succinate and acetate pathways are linked.
Indeed, we observe a correlation between the cellular NADH-FRD activity and acetate production, when glucose is the only carbon source available (Fig. 9) . Van Hellemond and colleagues showed that ASCT, the only well characterized acetate producing enzymes in T.
brucei (step 22 in Fig. 1 ), has a low affinity for succinate, one of its substrates (19) . Thus, an important reduction of succinate production, such as in the DFRDg/m1-B5.i cell line (92% reduction), may cause the observed reduction of acetate production by ASCT (75% reduction in this mutant cell line). Since succinate is also the end product of proline metabolism (21) Abbreviations: AA, amino acid; 1,3BPGA, 1,3-bisphosphoglycerate; C, cytochrome c; Cit, citrate; CoASH, coenzyme A; DHAP, dihydroxyacetone phosphate; F-6-P, fructose 6-phosphate; FBP, fructose 1,6-bisphosphate; G-3-P, glyceraldehyde 3-phosphate; G-6-P, glucose 6-phosphate; GLU, glutamate; Gly-3-P, glycerol 3-phosphate; IsoCit, isocitrate; 2Ket, Table I . 
